Delcath Systems Reports First Quarter 2025 Results and Business Highlights

Stock Information for aTyr Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About aTyr Pharma Inc.

Delcath Systems Issues Full Year 2025 Guidance
Delcath Systems to Participate at the Craig-Hallum 22nd Annual Investor Conference
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO(TM) in Liver-Dominant Metastatic Breast Cancer
Delcath Systems to Host First Quarter 2025 Earnings Call
Delcath Systems Announces Publication of Comparative Analysis from Randomized Portion of FOCUS Study in Metastatic Uveal Melanoma
Beta Bionics Announces Board Appointment of Gerard Michel
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.